Does human kallikrein gene delivery reduce blood pressure, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats on a high-salt diet?
Adenovirus-mediated human kallikrein gene delivery attenuates salt-induced hypertension, cardiac hypertrophy, and renal injury in a rat model.
The tissue kallikrein-kinin system has been documented to be involved in the pathogenesis of hypertension and renal diseases. To investigate the protective effects of kallikrein gene delivery on salt-induced renal damage, cardiac dysfunction, and hypertension, adenovirus harboring the human tissue kallikrein gene under the control of the cytomegalovirus promoter Ad.CMV-cHK was delivered into Dahl salt-sensitive (Dahl-SS) rats fed to a high-salt (4% NaCl) diet. A single intravenous injection of Ad.CMV-cHK resulted in a significant reduction of blood pressure beginning 2 days post injection and the effect lasted for 4 weeks. The human kallikrein mRNA was detected in rat heart, kidney, lung, liver, and adrenal gland; immunoreactive human kallikrein can be measured in the liver, kidney, sera, and urine of rats receiving kallikrein gene delivery. Following Ad.CMV-cHK injection, a significant increase in urine excretion, urinary sodium output, kinin, and cGMP level was observed. Kallikrein gene delivery caused a significant reduction in the left ventricular mass and cardiomyocyte size as well as inhibition of glomerular sclerotic lesions and tubular dilatation. This study shows that adenovirus-mediated gene delivery in Dahl-SS rats fed a high-salt diet resulted in (i) prolonged reduction of blood pressure and increased urinary kinin and cGMP levels, consistent with blood pressure reductions mediated via kinin through a cGMP-dependent signal transduction pathway, (ii) inhibition of cardiac hypertrophy, and (iii) attenuation of renal injury. The ability of kallikrein gene transfer to produce a wide spectrum of beneficial effects makes it an excellent candidate in treating salt-related hypertension as well as cardiovascular and renal diseases. Human tissue kallikrein gene delivery in hypertensive Dahl salt-sensitive rats fed a high-salt diet produces sustained reduction of the systolic blood pressure, inhibition of cardiac hypertrophy, and attenuation of renal injury. These findings provide new insights into the role of the tissue kallikrein-kinin system in salt-related hypertension as well as cardiovascular and renal functions and may have significance in future therapeutic applications.
Chao et al. (1998) studied this question.